سعر سونيدير 0.25 مجم/2 مل 30 أمبول للاستنشاق 2022

Sonidair budesonide 0.25 mg/2 ml nebuliser suspension, 30 single-dose ampoules for inhalation, by MDI Pharma; inhaled glucocorticoid for asthma maintenance.

• Maintenance treatment of asthma and prophylactic therapy in children 12 months to 8 years of age; not for relief of acute bronchospasm.Population: Children 12 months to 8 yearsDailyMed (U.S. National Library of Medicine)

• Most common (incidence 3% or more): respiratory infection, rhinitis, coughing, otitis media, viral infection, moniliasis, gastroenteritis, vomiting, diarrhoea, abdominal pain, ear infection, epistaxis, conjunctivitis, rash.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Primary treatment of status asthmaticus or other acute asthma episodes requiring intensive measures; hypersensitivity to budesonide or any ingredient.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Oral and pharyngeal Candida infection may occur; rinse the mouth after inhalation.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not for relief of acute bronchospasm.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity reactions including anaphylaxis, rash, urticaria, angioedema and bronchospasm; discontinue if they occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Strong CYP3A4 inhibitors (e.g. ketoconazole, ritonavir, atazanavir, clarithromycin, itraconazole)May increase systemic budesonide exposure and corticosteroid adverse effects; use caution with long-term coadministration.DailyMed (U.S. National Library of Medicine)

• No adequate well-controlled studies of the inhalation suspension in pregnancy; published studies have not shown that inhaled budesonide increases the risk of abnormalities. Subcutaneous budesonide was teratogenic and embryocidal in rats and rabbits.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Budesonide is present in human milk (infant oral dose about 0.3-1% of the inhaled maternal dose with a dry powder inhaler); weigh the benefits of breastfeeding against the maternal need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Budesonide: Binds glucocorticoid receptors to suppress inflammatory gene expression in the airways.